Abstract
(3939 Views) |
چکیده |
Full-Text (PDF)
(2264 Downloads)
|
Highlights
Conclusion: The systems biology approach can provide appropriate results relate to patient survival analysis. In this study, some genes were identified to be used as prognostic biomarkers in experimental studies related to the OS in the HER2-enriched subgroup. These genes can be considered potential candidates for therapeutic targets in this group of patients.